SHW
61
2
NTRS
39
2
NVDA
60
-5
CHK
5
-7
CTAS
64
2
ZTS
49
20
TRV
43
-3
BSX
70
2
AVGO
57
-14
O
37
-2
HPE
46
-5
VLO
33
-5
KO
52
5
PYPL
39
4
PM
52
-4
AIZ
64
-2
C
37
-2
EFX
55
-2
PVH
63
5
DAL
48
-2
SHW
61
2
NTRS
39
2
NVDA
60
-5
CHK
5
-7
CTAS
64
2
ZTS
49
20
TRV
43
-3
BSX
70
2
AVGO
57
-14
O
37
-2
HPE
46
-5
VLO
33
-5
KO
52
5
PYPL
39
4
PM
52
-4
AIZ
64
-2
C
37
-2
EFX
55
-2
PVH
63
5
DAL
48
-2
Financhill
Back

AAM S&P Emerging Markets Hi Div Val ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
50

EEMD
AAM S&P Emerging Markets Hi Div Val ETF

Last Price:
18.47
Seasonality Move:
-3.37%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
50
AAM S&P Emerging Markets Hi Div Val ETF (EEMD) is a Sell

Is AAM S&P Emerging Markets Hi Div Val ETF a Buy, Sell or Hold?

  • The current AAM S&P Emerging Markets Hi Div Val ETF [EEMD] share price is $18.48. The Score for EEMD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • EEMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EEMD Stock Price Chart

What is AAM S&P Emerging Markets Hi Div Val ETF's stock price today?

  • The AAM S&P Emerging Markets Hi Div Val ETF share price today is $18.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EEMD is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

EEMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 46.32 Sell
Chaikin Money Flow: 1267 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.29 - 19.21) Sell
Bollinger Bands (100): (18.25 - 19.07) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

EEMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.29 Buy
20-day SMA: 18.58 Sell
50-day SMA: 18.61 Sell
200-day SMA: 18.53 Sell
8-day EMA: 18.38 Buy
20-day EMA: 18.52 Sell
50-day EMA: 18.62 Sell
200-day EMA: 18.53 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

AAM S&P Emerging Markets Hi Div Val ETF Earnings Growth & EEMD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

AAM S&P Emerging Markets Hi Div Val ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):